• Tells us who's actually interested — clinicians, pharma, researchers, patients — so we prioritize the right first customers.
  • Gives us structured, exportable evidence for grant and investor conversations, not just anecdotes.
  • Lets us follow up directly with anyone who wants a deeper conversation.

Share your interest

Your response is submitted directly to us and helps us understand who's interested in NeuroPenetrance — nothing else is stored on this site.